Kentucky Horse Racing Commission looking into regulating compounders

Kentucky Horse Racing Commission chair Ned Bonnie

The commissioner of the Kentucky Horse Racing Commission announced that the organization is looking into ways it can add regulatory oversight of drug compounders. The action comes after a year that has seen horse deaths at a training center and other issues related to equine drug compounders. Rules committee chair Ned Bonnie said it has become a serious issue for horse racing in Kentucky and other states. There is little federal oversight of compounders compared to the regulation of pharmaceutical companies that manufacture drugs. Article

Suggested Articles

The United Nations’ 2030 Agenda for Sustainable Development lays out a host of priorities including “food security and nutrition,” an ambitious plan to…

Starting next year, drugmakers that market antibiotics for food animals will face tough new FDA rules limiting their use. So now some pharma companies are…

The USDA plans to hold manufacturers of veterinary biotech drugs to new, strict standards on labeling. Although companies will have between four and six years…